Destination
Mexico
- Latest exports
- $21.1M
- Market share
- 71.4%
- Growth
- +19.5%
- Access
- FTA reported
- Signal
- Stable
T3 · Product exporter position
USA, Puerto Rico and US Virgin Islands exports of Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments (HS 300670)
See where USA, Puerto Rico and US Virgin Islands stands in pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments: export scale, destination breadth, market position, growth, and reported trade history.
Latest exports
$97.5MLatest observed lane totalDestination markets
146Reported active marketsThree-year growth
+13%Annualized changeDestination HHI
883Destination concentrationWeighted share
51.2%Reported market positionExporter evidence
How strong is USA, Puerto Rico and US Virgin Islands in Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments?
Reported exporter totals and calculated indicators for HS 300670. Values retain their observed coverage period.
Exporter scale
Latest exports$97.5M
Current 2024 exports$96.2M
Three-year average$87.8M
Historical peak$956.2M
Market position
Active destinations146
Destination HHI883
Weighted share51.2%
Share change+2.9 pp
Competitiveness
Three-year growth+13%
Volatility1.4
Maximum drawdown99.1%
TrendRapid growth
| Measure | Value | What it describes |
|---|---|---|
| Exporter | USA, Puerto Rico and US Virgin Islands | Country represented by this profile |
| Latest observed exports | $97.5M | Sum of latest observed destination-lane values |
| Current 2024 exports | $96.2M | Common-year comparison where reported |
| Three-year growth | +13% | Annualized change in exporter totals |
| Five-year growth | +5.5% | Annualized change in exporter totals |
| Leading destination | MEX | Destination with the largest observed export value |
| Leading destination share | 21.7% | Share of observed exporter totals |
| Destination concentration | 883 | HHI across destination markets |
| Weighted share change | +2.9 pp | Value-weighted latest change in market share |
| Limited-history lanes | 7.3% | Share of lanes with shorter history |
Destination markets
Where does USA, Puerto Rico and US Virgin Islands sell pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments?
Leading destination observations ranked by reported export value, with market position and access context.
| Destination | Latest exports | Market share | Growth | Access | Signal |
|---|---|---|---|---|---|
| Mexico | $21.1M | 71.4% | +19.5% | FTA reported | Stable |
| China | $13.2M | 74.3% | +16.6% | 0.3% tariff | Stable |
| Canada | $8.3M | 78.2% | -7.8% | FTA reported | Slowing |
| Netherlands | $5.9M | 0.5% | +30.3% | 0.1% tariff | Stable |
| Australia | $5.5M | 49.7% | +63.5% | FTA reported | Slowing |
| United Kingdom | $3.8M | 18.4% | +44.7% | Not reported | Slowing |
| Germany | $2.6M | 20.8% | +6.3% | 0.1% tariff | Slowing |
| France | $627.2K | 4% | -3.3% | 0.1% tariff | Declining |
| Russia | $319.1K | 2% | +4.7% | 0.1% tariff | Stable |
Destination
China
- Latest exports
- $13.2M
- Market share
- 74.3%
- Growth
- +16.6%
- Access
- 0.3% tariff
- Signal
- Stable
Destination
Canada
- Latest exports
- $8.3M
- Market share
- 78.2%
- Growth
- -7.8%
- Access
- FTA reported
- Signal
- Slowing
Destination
Netherlands
- Latest exports
- $5.9M
- Market share
- 0.5%
- Growth
- +30.3%
- Access
- 0.1% tariff
- Signal
- Stable
Destination
Australia
- Latest exports
- $5.5M
- Market share
- 49.7%
- Growth
- +63.5%
- Access
- FTA reported
- Signal
- Slowing
Destination
United Kingdom
- Latest exports
- $3.8M
- Market share
- 18.4%
- Growth
- +44.7%
- Access
- Not reported
- Signal
- Slowing
Destination
Germany
- Latest exports
- $2.6M
- Market share
- 20.8%
- Growth
- +6.3%
- Access
- 0.1% tariff
- Signal
- Slowing
Destination
France
- Latest exports
- $627.2K
- Market share
- 4%
- Growth
- -3.3%
- Access
- 0.1% tariff
- Signal
- Declining
Destination
Russia
- Latest exports
- $319.1K
- Market share
- 2%
- Growth
- +4.7%
- Access
- 0.1% tariff
- Signal
- Stable
Price intelligence
How does USA, Puerto Rico and US Virgin Islands's price position vary?
Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.
Highest reported price
CYM: $3.7M / ton.
Lowest reported price
Liberia: $61.1 / ton.
Median price
$18.9K / ton across reported markets.
Export trend
Reported export history
Annual observations for USA, Puerto Rico and US Virgin Islands and HS 300670 where available.
| Year | Exports | Year-on-year change | Active destinations |
|---|---|---|---|
| 2010 | $29.4M | +27.2% | 140 |
| 2011 | $33.2M | +12.7% | 138 |
| 2012 | $33.7M | +1.5% | 140 |
| 2013 | $36.1M | +7% | 141 |
| 2014 | $39.8M | +10.4% | 141 |
| 2015 | $48.7M | +22.3% | 141 |
| 2016 | $50.4M | +3.5% | 152 |
| 2017 | $56.8M | +12.7% | 138 |
| 2018 | $59.3M | +4.4% | 150 |
| 2019 | $73.6M | +24.2% | 142 |
| 2020 | $56.8M | -22.8% | 156 |
| 2021 | $66.6M | +17.2% | 148 |
| 2022 | $81.3M | +22.2% | 142 |
| 2023 | $86.0M | +5.7% | 142 |
| 2024 | $96.2M | +11.9% | 146 |
Exporter context
USA, Puerto Rico and US Virgin Islands economy and trade network
The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300670.
USA, Puerto Rico and US Virgin Islands has reported exports of $1.9T and a trade balance of -$1.3T in 2024.
Available structural indicators include 25.3% trade openness, 21.9% investment, and 270 active trade partners.
Reported values
Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.
Calculated indicators
Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.
Coverage
Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.
Frequently asked questions
Questions about USA, Puerto Rico and US Virgin Islands pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments exports
Quick answers based on the figures and coverage shown on this page.
How strong is this exporter?+
Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.
Which markets are most important?+
The destination table ranks reported markets by the latest observed export value.
Does the price section show quotes?+
No. It summarizes reported trade value and quantity observations converted to unit values.
What should be checked next?+
Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.